“…CphA, a MBL found in A. dhakensis, A. veronii , and A. hydrophila ( Wu et al, 2012a ), has a specific substrate profile of hydrolyzing carbapenems but not penicillins or cephalosporins, if compared with other MBLs ( Segatore et al, 1993 ). However, CphA carbapenemase production is not easily detected by the conventional susceptibility test, unless a large inoculum or additional tests (e.g., modified Hodge test, ertapenem MIC or Carba NP test) are applied ( Rossolini et al, 1995 ; Wu et al, 2012a ; Sinclair et al, 2016 ). Carbapenem therapy for cphA- carrying Aeromonas infections remains controversial, because of the clinical concern that carbapenem monotherapy may fail in treating MBL-producing aeromonads infections with a high bacterial burden, such as peritonitis/abdominal sepsis or soft tissue infections ( Wu et al, 2012a ).…”